Feb 24, 2010
Cadwalader, Wickersham & Taft LLP, one of the world’s leading international law firms, acted as lead counsel to Pfizer in the $68 billion cash and stock acquisition of Wyeth Inc., a transaction named Corporate Deal of the Year at the M&A Atlas Awards Gala held at the Waldorf Astoria Hotel in New York City on February 24, 2010.
The awards recognize excellence in deals valued above a billion USD from all corners of the globe. The 2010 annual awards gala and ceremony attendees included top dealmaker from China to Middle East, Europe and the Americas. Award categories were expanded to accurately reflect diversities in size, sectors and geographies. Winners are selected based on "deal-performance" criteria per award category. Winners and award recipients must attend the gala ceremony to be officially recognized in the company of their clients, colleagues and peers from the industry.
“We are proud that in the challenging investment environment of 2009, we were able to assist clients, such as Pfizer, in developing the creative strategies needed to get their deals done. We also are pleased that Global M&A Network has recognized this significant transaction.” said Chris White, Cadwalader’s Chairman.
The Cadwalader team was led by partner Dennis Block and also included partners Dorothy Auth, Jason Halper, Steve Herman, Stewart Kagan, Jonathan Kanter, William Mills, Richard Nugent, Rick Rule, and Linda Swartz; special counsel Mark Holdsworth; and associates Ryan Andreoli, Joshua Apfelroth, Stephen Blank, Jonathan Bliley, Adam Brajer, Erika Engelson, Anna Erenburg, Cheryl Howard, Jonathan Karas, James Langston, Elizabeth Mattern, Braden McCurrach, Brendan O’Leary, Michael Rosado, Christopher Slimm, and Ariel Zell.
We have provided a compendium of our materials to help you navigate this unprecedented environment.